Explore our company news, announcements and updates

November 3, 2026

FDA Grants Merck Animal Health Emergency Use Authorization (EUA) for BRAVECTO® (fluralaner) Chews for the Treatment of New World Screwworm Infestations in Dogs and Puppies

November 2, 2026

Merck Animal Health Launches NOBIVAC® NXT Rabies for Dogs and Cats in the United States

November 1, 2026

Merck Animal Health Study Identifies Fetal Bovine Serum in Vaccines as Key Risk Factor for Spinal Deformities in Farmed Atlantic Salmon

October 12, 2026

Merck Animal Health to Showcase Latest Innovations in Veterinary Medicine at WSAVA 2026

October 1, 2026

Merck Animal Health Highlights Landmark Clinical Research on Gilvetmab, the First Caninized Immune Checkpoint Inhibitor for Canine Oncology in the Journal of Veterinary Internal Medicine and Journal of the American Veterinary Medical Association

September 29, 2026

Merck Animal Health Showcases New Research Advancing Ruminant Health at World Buiatrics Congress

July 31, 2026

European Commission Grants Marketing Authorization for NOBIVAC NXT HCPChFeLV from Merck Animal Health

July 20, 2026

Study from Merck Animal Health Reveals Opportunity to Increase Feline Vaccination through Knowledge Sharing Between Veterinarians and Cat Owners

June 17, 2026

Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages

June 11, 2026

Merck Animal Health to Acquire TARGAN

June 4, 2026

Merck Animal Health Reinforces Commitment to Help Protect U.S. Livestock from New World Screwworm Threat

June 4, 2026

New Research from Merck Animal Health Reveals “Hidden” Parasitic Infections Cost Global Dairy Industry Billions Each Year

12 3 4 Next